Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Complement Factor H Polymorphism and Age-Related Macular Degeneration
2005 StandoutScience
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Cost-Effectiveness of Aspirin Treatment in the Primary Prevention of Cardiovascular Disease Events in Subgroups Based on Age, Gender, and Varying Cardiovascular Risk
2008
Primary Prevention of Ischemic Stroke
2006
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
2011
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
2010 Standout
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis
2010 Standout
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 Standout
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Inflammation and Hemostasis Biomarkers for Predicting Stroke in Postmenopausal Women: The Women's Health Initiative Observational Study
2008
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
COPD Guidelines: A Review of the 2018 GOLD Report
2018 Standout
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Guidelines for the Primary Prevention of Stroke
2010
Database resources of the National Center for Biotechnology Information: update
2003 Standout
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
2009 Standout
Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity
2004
Chronic kidney disease
2011 Standout
Incidence of stroke is related to carotid IMT even in the absence of plaque
2004
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Update on Trial Registration 11 Years after the ICMJE Policy Was Established
2017
Association of Polymorphisms in the CRP Gene With Circulating C-Reactive Protein Levels and Cardiovascular Events
2006
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
2018 Standout
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
2009
C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients
2006
Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis
2005
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Cardiovascular Mortality Risk in Chronic Kidney Disease
2005
C-Reactive Protein Is a Determinant of First-Ever Stroke: Prospective Nested Case-Referent Study
2009
Increased Carotid Intima-Media Thickness and Serum Inflammatory Markers in Obstructive Sleep Apnea
2005
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Response to Indacaterol/Glycopyrronium (IND/GLY) by Sex in Patients with COPD: A Pooled Analysis from the IGNITE Program
2017
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Emotion Recollected in Tranquility: Lessons Learned from the COX-2 Saga
2010
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
2009 Standout
Lipoprotein (a) and Stroke
2007
C-Reactive Protein and the 10-Year Incidence of Coronary Heart Disease in Older Men and Women
2005
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force
2009
Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events
2004
Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke
2005
10-Year Update on Study Results Submitted to ClinicalTrials.gov
2019
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
2009
Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness
2007 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Pathophysiology of Sleep Apnea
2010 Standout
Role of C-Reactive Protein in Cardiovascular Disease
2003
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
2009 Standout
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
2009 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Aspirin as an Adjunct to Screening for Prevention of Sporadic Colorectal Cancer: A Cost-Effectiveness Analysis
2001
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
2010 Standout
High Serum C-Reactive Protein Level Is Not an Independent Predictor for Stroke
2006
Discrepancy between strong cephalic arterial dilatation and mild headache caused by prostaglandin D2(PGD2)
2010
Endothelial Function and Dysfunction
2007 Standout
Works of Chau Thach being referenced
LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD
2015
The effect of MK-0524, a prostaglandin D2 receptor antagonist, on prostaglandin D2-induced nasal airway obstruction in healthy volunteers
2007
Effects of Etoricoxib and Comparator Nonsteroidal Anti‐Inflammatory Drugs on Urinary Sodium Excretion, Blood Pressure, and Other Renal Function Indicators in Elderly Subjects Consuming a Controlled Sodium Diet
2007
Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
2016
Aspirin for primary prevention of cardiovascular events
1998
Lp(a) Lipoprotein, Vascular Disease, and Mortality in the Elderly
2003
C-Reactive Protein, Carotid Intima-Media Thickness, and Incidence of Ischemic Stroke in the Elderly
2003
C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly
2003